MR
Mohan Reddy Enaganuri
About Mohan Reddy Enaganuri
Data last updated:
Mohan Reddy Enaganuri is a Director at Hatri Pharma Private Limited (since 2010), Director at Emr Laboratories Private Limited (since 2016) and Director at Reddys Therapeutics Private Limited (since 2016), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Chemicals. The 4 current companies with reported revenue have a combined latest revenue of ₹89.4 Lakh; the largest is Hatri Pharma Private Limited at ₹71.7 Lakh (FY 2025). Earlier, Mohan Reddy Enaganuri was a Director at Venkata Narayana Active Ingredients Private Limited (2010–2015) and Director at Green Gold Bio Coal Private Limited (from 2012).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Jul 2010 | 2010 | ₹71.7 Lakh (FY 2025) | Active | |
| Director | 20 Oct 2016 | 2016 | ₹11.5 Lakh (FY 2023) | Active | |
| Director | 21 Oct 2016 | 2016 | ₹5.9 Lakh (FY 2022) | Active | |
| Director | 09 Sep 2009 | 2009 | ₹31,630 (FY 2023) | Active | |
| Director | 31 Dec 2012 | 2012 | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 May 2010 | 2005 | ₹272 Cr (FY 2025) | Active | |
| Director | 27 Apr 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mohan Reddy Enaganuri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rebala Rupakala | 07623584 | Hatri Pharma Private Limited , Emr Laboratories Private Limited and 1 more | Director |
| Sumalatha Ambarapu | 10272329 | Hatri Pharma Private Limited | Director |
| Mohan Sai Sundar Reddy Devarapalli | 11007217 | Reddys Therapeutics Private Limited | Director |
| Sathish Kumar Mohan Rao | 08210524 | Chemsynth Laboratories Private Limited | Director |
| Swaminathan Ramesh | 08449996 | Chemsynth Laboratories Private Limited | Director |
| Vijender Medamoni | 02720822 | Chemsynth Laboratories Private Limited | Director |
| Giridhara Gopal Pulleti | 01594062 | Abhusha Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohan Reddy Enaganuri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohan Reddy Enaganuri
Mohan Reddy Enaganuri currently holds 5 directorships: Hatri Pharma Private Limited (Director, since 21 Jul 2010, revenue ₹71.7 Lakh (FY 2025)); Emr Laboratories Private Limited (Director, since 20 Oct 2016, revenue ₹11.5 Lakh (FY 2023)); Reddys Therapeutics Private Limited (Director, since 21 Oct 2016, revenue ₹5.9 Lakh (FY 2022)); Chemsynth Laboratories Private Limited (Director, since 09 Sep 2009, revenue ₹31,630 (FY 2023)); Abhusha Pharma Private Limited (Director, since 31 Dec 2012).
Mohan Reddy Enaganuri was first appointed on 09 Sep 2009 as Director at Chemsynth Laboratories Private Limited. The most recent appointment on record is 21 Oct 2016 at Reddys Therapeutics Private Limited.
The 4 current companies of Mohan Reddy Enaganuri that report revenue have a combined latest revenue of ₹89.4 Lakh: Hatri Pharma Private Limited ₹71.7 Lakh (FY 2025); Emr Laboratories Private Limited ₹11.5 Lakh (FY 2023); Reddys Therapeutics Private Limited ₹5.9 Lakh (FY 2022); Chemsynth Laboratories Private Limited ₹31,630 (FY 2023).
Mohan Reddy Enaganuri held 2 earlier board appointments: Venkata Narayana Active Ingredients Private Limited (Director, 21 May 2010 to 04 Feb 2015); Green Gold Bio Coal Private Limited (Director, from 27 Apr 2012).
The current boards of Mohan Reddy Enaganuri's companies include Rebala Rupakala (Hatri Pharma Private Limited), Sumalatha Ambarapu (Hatri Pharma Private Limited), Mohan Sai Sundar Reddy Devarapalli (Reddys Therapeutics Private Limited), Sathish Kumar Mohan Rao (Chemsynth Laboratories Private Limited), Swaminathan Ramesh (Chemsynth Laboratories Private Limited), Vijender Medamoni (Chemsynth Laboratories Private Limited), among others.